Managing the side effects of sunitinib: a guide to empowering the patient
Clinical Previous    

Managing the side effects of sunitinib: a guide to empowering the patient

Lynda Pyle Research nurse, Department of Medicine, Royal Marsden Hospital, London
Deborah Beirne Senior research nurse cancer research, UK Clinical Centre, St James’s University Hospital, Leeds
Joanne Bird Research sister, Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, Sheffield
Linda Hoggarth Research nurse, Academic oncology, Princess Royal Hospital, Hull
Clare Jamieson Clinical research nurse, Cancer Research UK, Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham
Lynette Lane Oncology research sister, Clinical Trials Unit, Velindre Cancer Centre, Cardiff
Barbara Mayne Senior research nurse, Upper GI/Urology, Scottish Cancer Research Network (South East), Ward One, Western General Hospital, Edinburgh
Tina Pritchard Senior clinical research sister, Medical oncology, Christie Hospital NHS Foundation Trust, Manchester
Louisa Stone Research nurse, Sarcoma Unit, Royal Marsden Hospital, London
Alison Stretch Oncology research nurse, Cancer Institute, Singleton Hospital, Swansea
Amanda Watson Research sister, Cancer Research UK Clinical Centre, Southampton General Hospital
Jane Woods Research sister, Royal Surrey County Hospital NHS Trust, Guildford

In June 2007, 12 research nurses involved in the clinical trials of sunitinib in the UK met to discuss the common side effects they had encountered with the drug. This article represents their efforts to document these side effects and provide practical guidance on how to prevent or manage them, so that nurses who are less familiar with sunitinib will be aware of its toxicities and be confident about dealing with the side effects as the drug begins to move out of the clinical trial setting and into the clinic.

Cancer Nursing Practice. 7, 4, 42-46. doi: 10.7748/cnp2008.

You need a subscription to read the full article